Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin M

Source: Food and Drugs Administration--Recalls/Safety Alerts